SLC2A4 Knockout Huh-7 Cell Line
Cat.No.:
EDC08334
Species:
Human
Cell Name:
Huh-7
Gene:
SLC2A4
Gene ID:
6517
Size:
1×10⁶cells
SLC2A4 Knockout Huh-7 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08334 |
|---|---|
| Product Name | SLC2A4 Knockout Huh-7 Cell Line |
| Species | Human |
| Cell Line | Huh-7 |
| Cellosaurus ID | CVCL_0336 |
| Cell Line Synonyms | HuH-7, HUH-7, HuH7, Huh7, HUH7, HUH7.0, JTC-39, Japanese Tissue Culture-39 |
| Gene ID | |
| Gene | SLC2A4 |
| Summary |
This gene is a member of the solute carrier family 2 (facilitated glucose transporter) family and encodes a protein that functions as an insulin-regulated facilitative glucose transporter. In the absence of insulin, this integral membrane protein is sequestered within the cells of muscle and adipose tissue. Within minutes of insulin stimulation, the protein moves to the cell surface and begins to transport glucose across the cell membrane. Mutations in this gene have been associated with noninsulin-dependent diabetes mellitus (NIDDM). [provided by RefSeq, Jul 2008]
|
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 70% Complete medium + 20% FBS + 10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: Huh-7 | STR Info (Cell bank) Cell Line: Huh-7 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 11 | 11 | ||
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 15 | ||
| D5S818 | 12 | 12 | ||
| D7S820 | 11 | 11 | ||
| D8S1179 | 14 | 14 | 15 | |
| D13S317 | 10 | 11 | 10 | 11 |
| D16S539 | 10 | 10 | ||
| D18S51 | 15 | 15 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 30 | 30 | ||
| FGA | 22 | 23 | 22 | 23 |
| Penta D | 12 | 12 | ||
| Penta E | 11 | 11 | ||
| TH01 | 7 | 7 | ||
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 16 | 18 | 16 | 18 |
| D6S1043 | 13 | 15 | 13 | 15 |
| D12S391 | 20 | 21 | 20 | 21 |
| D2S441 | 12 | 14 | 12 | 14 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC2A4 function, SLC2A4 Knockout Huh-7 Cell Line or SLC2A4 overexpression Huh-7 Cell Line?
The choice depends on whether you are studying SLC2A4 (GLUT4)'s role as the insulin-responsive glucose transporter or using heterologous expression for biochemical studies. Note that GLUT4 is principally expressed in skeletal muscle and adipose tissue where it mediates insulin-stimulated glucose uptake — Huh-7 (hepatocellular carcinoma) is not the physiological GLUT4-expressing context. The Knockout line in Huh-7 is most useful as a clean genetic background for heterologous GLUT4 expression studies and for confirming complete loss in cells with low baseline expression.
Overexpression is generally more functionally informative than knockout for GLUT4 research in Huh-7. The EDITGENE Knockout is useful for biochemical studies, GLUT4 trafficking research using heterologous expression, and rescue with wild-type or trafficking-mutant GLUT4 variants. For physiological insulin-stimulated glucose uptake research, muscle (L6, C2C12) or adipocyte (3T3-L1) models are more appropriate.
What are the application scenarios for this model?
Primary applications:
• Heterologous GLUT4 expression studies: rescue with wild-type or trafficking-mutant GLUT4 in a clean knockout background, useful for in vitro biochemistry.
• GLUT4 trafficking biochemistry: GSV (GLUT4 storage vesicle) component interaction studies in heterologous expression contexts.
• Glucose transport studies: 2-deoxyglucose uptake assays in the clean knockout background to confirm GLUT4-specific contributions in heterologous expression.
• Antibody validation: critical genetic specificity control for anti-GLUT4 antibodies.
EDITGENE recommends this model primarily for in vitro biochemistry and antibody specificity validation. Physiological insulin-stimulated glucose uptake research requires L6, C2C12, or 3T3-L1 differentiated adipocyte models.
Is this SLC2A4 Knockout Huh-7 Cell Line compatible with overexpression rescue experiments?
Yes, with heterologous expression considerations specific to Huh-7 context:
• Construct design: use a codon-modified SLC2A4 sequence with a small N- or C-terminal tag (FLAG, HA). GLUT4 has 12 transmembrane domains — both N- and C-terminal cytoplasmic tags are typically tolerated.
• GSV trafficking studies: rescue with GFP-tagged GLUT4 enables imaging-based GSV trafficking analysis in heterologous expression, though insulin-stimulated translocation requires muscle/adipocyte signaling machinery.
• Trafficking-mutant rescue: GLUT4 N-terminal phenylalanine motif (F5) or C-terminal dileucine motif mutations disrupt intracellular retention and enable trafficking studies.
• Functional readout: in Huh-7, glucose transport activity can be measured by 2-deoxyglucose uptake, though insulin-responsive translocation is not preserved without muscle/adipocyte context.
Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation for heterologous biochemical studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.